Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.63537 | 60 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.89715 | 65 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.63035 | 61 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.69707 | 62 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.56501 | 60 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.64281 | 59 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.63208 | 59 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.61604 | 60 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.62609 | 61 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.39664 | 70 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.91337 | 65 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.70209 | 62 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.63503 | 61 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.51809 | 59 |